BIOSPECIFICS TECHNOLOGIES CO (BSTC)
Institutional ownership reported to the SEC as of Q4 2020, across 9 quarters.
1
Reporting holders
$203.6K
Reported value
0.0%
Held as options
-110
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| UBS ASSET MANAGEMENT AMERICAS INC | $203.6K | 2,300 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2020 | 1 | $203.6K | 2,300 | 1 | 0 | 0 | 0.0% |
| Q3 2020 | 111 | $254.0M | 4,803,067 | 9 | 37 | 40 | 0.0% |
| Q2 2020 | 115 | $294.3M | 4,802,174 | 17 | 43 | 37 | 0.0% |
| Q1 2020 | 112 | $261.8M | 4,629,221 | 13 | 22 | 54 | 0.0% |
| Q4 2019 | 110 | $269.2M | 4,727,427 | 14 | 39 | 31 | 0.0% |
| Q3 2019 | 113 | $247.3M | 4,619,884 | 11 | 41 | 34 | 0.0% |
| Q2 2019 | 114 | $259.5M | 4,346,529 | 18 | 48 | 34 | 0.0% |
| Q1 2019 | 115 | $264.3M | 4,232,871 | 15 | 34 | 41 | 0.0% |
| Q4 2018 | 106 | $266.9M | 4,405,198 | 4 | 1 | 4 | 0.0% |